We are very proud to have recruited the first patients in the UK to BICCC, a new colorectal clinical trial aimed at increasing disease-free survival.
The public will be able to observe the meeting from the widely available video conferencing platform Zoom.
APPROACH is a clinical trial looking at proton beam therapy for people with a brain tumour called oligodendroglioma and is the first of its kind for brain tumours at Velindre.
The programme recently reached a significant milestone as we took delivery of the two Linac machines which will deliver our treatments.
We are delighted that the first meeting of the Trust’s Patient and Carer Partnership Board (PCPB) took place on Wednesday 16 October 2024.
Between July and September 2024, the team successfully applied for £1.3 million worth of benefits and grants to over 300 patients and their families.
The prize was presented as part of the Trust’s Employee Excellence Awards ceremony which took place this week at Coleg y Cymoedd in Nantgarw.